Pulmonary arterial hypertension (PAH) is a rare form of pulmonary hypertension. It occurs because progressive vascular ...

In high-risk patients with pulmonary arterial hypertension, Merck ’s fusion protein therapeutic Winrevair reduced the ...

PAH treatments show similar efficacy in reducing morbidity/mortality in CHD-PAH and PAH patients, with a 50% risk reduction in CHD-PAH. Improvements in 6-minute walking distance and NT-proBNP ...

Typically, generic drugs cost less than brand-name drugs. Tadalafil is available as brand names Adcirca and Alyq, which treat PAH, and Cialis, which treats ED, BPH, or both. If your doctor ...

[80] ARIES-1 randomized 202 patients with PAH to either placebo or ambrisentan 5 mg, or 10 mg once daily, and ARIES-2 randomized 192 PAH patients to ambrisentan 2.5 mg or 5 mg once daily for a ...

CHICAGO -- Adding sotatercept (Winrevair) to the treatment regimen for pulmonary arterial hypertension (PAH) in high-risk ...

Liquidia's collaboration with Sandoz and development of new products like L606 show promise. Learn why LQDA stock is a Hold.

I should note that PE is associated with PAH itself, not just with its treatment. Thus, researchers note how it occurs: PE has been known to occur with some approved drugs, including dasatinib.

Another study testing sotatercept as an early intervention for pulmonary arterial hypertension (PAH) is anticipated to ...

Sotatercept, an activin signaling inhibitor, was associated with improved outcomes in patients with advanced pulmonary ...

Marc Humbert, M.D., Ph.D., professor of respiratory medicine at Université Paris-Saclay and Inserm, believes that recent ...